Expression Profiling of Hspb1 and Tp53 Genes through RT-qPCR in Different Cancer Types of Canis familiaris

Diagnostic molecular marker studies are in vogue to have insight of most prevalent animal diseases including cancer. Gene expression profiling of pro and anti-apoptotic genes was conducted in dog Lymphoma, CTVT, SCC, granuloma, perianal adenocarcinoma and mammary tumors. Cancerous tissues of 21 affe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Iranian journal of biotechnology 2017, Vol.15 (3), p.186-193
Hauptverfasser: Saif, Rashid, Awan, Ali Raza, Tayyab, Muhammad, Ellahi Babar, Masroor, Khalid Mahmood, Asim, Ullah, Zia, Zia, Saeeda, Wasim, Muhammad
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Diagnostic molecular marker studies are in vogue to have insight of most prevalent animal diseases including cancer. Gene expression profiling of pro and anti-apoptotic genes was conducted in dog Lymphoma, CTVT, SCC, granuloma, perianal adenocarcinoma and mammary tumors. Cancerous tissues of 21 affected animals were obtained. Total RNA was extracted followed by cDNA synthesis. Comparative Ct method via assay (RT-qPCR) was used to quantify corresponding mRNA molecules, and , as normalized by as the reference gene . showed ectopic expression in lymphoma, CTVT and mammary tumors; its down-regulation was observed in granuloma and oral SCC with fold difference (FD) of ±35. Similarly, as the tumor suppressor gene with pro-apoptotic properties, showed up-regulation in all tumor types, notably 80% of mammary tumors and 60% of CTVT. The FD values were 33.31 and 2.27, respectively. Altered transcriptomic response of and was observed in all cancer types of . The resulting profile depicts the involvement of the genes in cancer pathways. Thus, the data might be helpful for diagnosis, prognosis, identification and classification of these widespread neoplasms in this species.
ISSN:1728-3043
2322-2921
DOI:10.15171/ijb.1505